Toll-like receptor 4-dependent activation of myeloid dendritic cells by leukocidin of Staphylococcus aureus

Microbes and Infection

Volumn 11, Issue 2, 2009, Pages 245-253

  Inden, Ken ^a   Kaneko, Jun ^b   Miyazato, Akiko ^a   Yamamoto, Natsuo ^a   Mouri, Shota ^b   Shibuya, Yoshiyuki ^b   Nakamura, Kiwamu ^a   Aoyagi, Tetsuji ^a   Hatta, Masumitsu ^a   Kunishima, Hiroyuki ^a   Hirakata, Yoichi ^a   Itoh, Yoshifumi ^b   Kaku, Mitsuo ^a   Kawakami, Kazuyoshi ^c  

^a Department of Infection Control   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD40; Dendritic cells; IL 12; Leukocidin; Staphylococcus aureus; TLR4

Indexed keywords

CD14 ANTIGEN; CD40 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; LEUKOCIDIN; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; POLYMYXIN B; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL STRAIN HEK293; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIGENS, CD40; BACTERIAL PROTEINS; CELL LINE; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; INTERLEUKIN-12 SUBUNIT P40; LEUKOCIDINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

MUS; ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 61549113489     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.11.013     Document Type: Article

References (28)

1. Williams R. Health carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol. Rev. 27 (1963) 56-71
2. Waldvogel F.A. Staphylococcus aureus. In: Mandekk G.L., Bennett J.E., and Dolin R. (Eds). Principles and Practice of Infectious Disease (2000), Churchill Livingstone, Philadelphia 2069-2092
3. Jarvis W.R. The epidemiology of colonization. Infect. Control Hosp. Epidemiol. 17 (1996) 47-52
4. Cosgrove S.E., Qi Y., Kaye K.S., Karchmer A.W., and Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect. Control Hosp. Epidemiol. 26 (2005) 166-174
5. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.E., and Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9 (2003) 978-984
6. Kaneko J., and Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxin: structures, pore-forming mechanism, and organization of the genes. Biosci. Biotechnol. Biochem. 68 (2004) 981-1003
7. Nishiyama A., Kaneko J., Harata M., and Kamio Y. Assembly of staphylococcal leukocidin into a pore-forming oligomer on detergent-resistant membrane microdomains, lipid rafts, inhuman polymorphonuclear leukocytes. Biosci. Biotechnol. Biochem. 70 (2006) 1300-1307
8. Noda M., Kato I., Hirayama T., and Matsuda F. Mode of action of staphylococcal leukocidin: effects of the S and F components on the activities of membrane-associated enzymes of rabbit polymorphonuclear leukocidin. Infect. Immun. 35 (1982) 38-45
9. Colin D.A., Mazurier I., Sire S., and Finck-Barbançon V. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect. Immun. 62 (1994) 3184-3188
10. König B., Prévost G., Piémont Y., and König W. Effects of Staphylococcus aureus leukocidin on inflammatory mediator release from human granulocytes. J. Infect. Dis. 171 (1995) 607-613
11. Kaisho T., and Akira S. Pleiotropic function of Toll-like receptors. Microbes Infect. 6 (2004) 1388-1394
12. Kaisho T., and Akira S. Regulation of dendritic cell function through toll-like receptors. Curr. Mol. Med. 3 (2003) 759-771
13. Kaisho T., and Akira S. TLR signaling. Cell Death Differ 13 (2006) 816-825
14. Seya T., and Matsumoto M. A lipoprotein family Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. Int. J. Biochem. Cell Biol. 34 (2002) 901-906
15. Zähringer U., Lindner B., Inamura S., Heine H., and Alexander C. TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213 (2008) 205-224
16. Miller S.I., Ernst R.K., and Bader M.W. Lps, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3 (2005) 36-46
17. Foti M., Granucci F., Pelizzola M., Beretta O., and Ricciardi-Castagnoli P. Dendritic cells in pathogen recognition and induction of immune responses: a functional genomics approach. J. Leukoc. Biol. 79 (2006) 913-916
18. Nariya H., Asami I., Ozawa T., Beppu Y., Izaki K., and Kamio Y. Improved method for purification of leukocidin and γ-hemolysin components from Staphylococcus aureus. Biosci. Biotechnol. Biochem. 57 (1993) 2198-2199
19. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77-92
20. Kawakami K., Tohyama M., Qifeng X., and Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lung of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 65 (1997) 1307-1312
21. Xia G., Miyazato A., Inden K., Nakamura K., Shiratori K., Nakagawa K., Miyazawa T., Suzuki K., Kaku M., and Kawakami K. Cryptococcus neoformans inhibits nitric oxide synthesis caused by CpG-oligodeoxynucleotide-stimulated macrophages in a fashion independent of capsular polysaccharide. Microbiol. Immunol. 52 (2008) 171-179
22. Werling D., and Jungi T.W. Toll-like receptors linking innate and adaptive immune response. Vet. Immunol. Immunopathol. 91 (2003) 1-12
23. Malley R., Henneke P., Morse S.C., Cieslewicz M.J., Lipsitch M., Thompson C.M., Kurt-Jones E., Paton J.C., Wessels M.R., and Golenbock D.T. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U.S.A. 18 (2003) 1966-1971
24. Younis A., Krifucks O., Fleminger G., Heller E.D., Gollop N., Saran A., and Leitner G. Staphylococcus aureus leukocidin, a virulence factor in bovine mastitis. J. Dairy Res. 72 (2005) 188-194
25. Freudenberg M.A., Tchaptchet S., Keck S., Fejer G., Huber M., Schütze N., Beutler B., and Galanos C. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infection: benefits and hazards of LPS hypersensitivity. Immunobiology 213 (2008) 193-203
26. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 15 (2000) 5392-5396
27. Fournier B., and Philpott D.J. Recognition of Staphylococcus aureus by the innate immune system. Clin. Microbiol. Rev. 18 (2005) 521-540
28. Stenzel W., Soltek S., Sanchez-Ruiz M., Akira S., Miletic H., Schlüter D., and Deckert M. Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am. J. Pathol. 172 (2007) 132-145